Discover the detailed record of transactions filed by Grossman Adam S, Chief Executive Officer. Insider active across 1 companies, notably Adma Biologics, INC.. Aggregated, 7 reports have been logged. Total volume traded: €172k. The latest transaction was filed on 11 May 2022 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Adam S. Grossman is the President and CEO of ADMA BIOLOGICS, INC. He leads the company and is responsible for implementing the overall strategy. Adam plays a key role in directing operations and developing new biological products.